韩国渗出性年龄相关性黄斑变性患病率和发病率的10年变化和预测。

IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Min Seok Kim, Seonghee Nam, Sang Jun Park, Jeongwoo Lee, Se Joon Woo
{"title":"韩国渗出性年龄相关性黄斑变性患病率和发病率的10年变化和预测。","authors":"Min Seok Kim, Seonghee Nam, Sang Jun Park, Jeongwoo Lee, Se Joon Woo","doi":"10.3346/jkms.2025.40.e128","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Updating the recent epidemiology of exudative age-related macular degeneration (AMD) is crucial for understanding the epidemiological trend of the disease, preparing healthcare strategies, and providing data for global comparisons. This study aimed to estimate the nationwide trend in prevalence and incidence of exudative AMD in Korea.</p><p><strong>Methods: </strong>In this nationwide population-based study using the National Health Insurance Service data, patients who have registration code for exudative AMD and aged 40 years or older were extracted from 2013 to 2022. Cumulative prevalence from 2013 onwards, annual prevalence, and incidence was estimated per 10,000 people. We also calculated age-standardized estimates using the World Health Organization population proportions. Linear regression to test time trend was performed. The annual prevalence and incidence were predicted using time series analysis.</p><p><strong>Results: </strong>The crude cumulative prevalence of exudative AMD was 42.7 in 2022, with men having a higher prevalence than women (51.3 vs. 34.6). The annual prevalence rose from 10.7 in 2013 to 22.5 in 2022 (age-standardized, <i>P</i> < 0.001). The incidence consistently increased from 2.8 in 2013 to 4.7 in 2022 (age-standardized, <i>P</i> = 0.001), with higher incidence in men than in women. The prevalence and incidence of exudative AMD were higher in older age groups and showed a faster increase with advancing age. The predicted annual prevalence and incidence of exudative AMD in 2040 are 46.2 and 8.4, respectively. The crude cumulative number of patients was 127,044 in 2022 and is projected to reach 230,899 in 2030 and 374,282 in 2040.</p><p><strong>Conclusion: </strong>The prevalence and incidence of exudative AMD in Korea has been increased annually, especially in the elderly group. With the Korean and global population aging, there will be a growing burden from visual impairment and medical expenses associated with exudative AMD.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 26","pages":"e128"},"PeriodicalIF":2.3000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12235191/pdf/","citationCount":"0","resultStr":"{\"title\":\"10-Year Change and Projection in Prevalence and Incidence of Exudative Age-Related Macular Degeneration in Korea.\",\"authors\":\"Min Seok Kim, Seonghee Nam, Sang Jun Park, Jeongwoo Lee, Se Joon Woo\",\"doi\":\"10.3346/jkms.2025.40.e128\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Updating the recent epidemiology of exudative age-related macular degeneration (AMD) is crucial for understanding the epidemiological trend of the disease, preparing healthcare strategies, and providing data for global comparisons. This study aimed to estimate the nationwide trend in prevalence and incidence of exudative AMD in Korea.</p><p><strong>Methods: </strong>In this nationwide population-based study using the National Health Insurance Service data, patients who have registration code for exudative AMD and aged 40 years or older were extracted from 2013 to 2022. Cumulative prevalence from 2013 onwards, annual prevalence, and incidence was estimated per 10,000 people. We also calculated age-standardized estimates using the World Health Organization population proportions. Linear regression to test time trend was performed. The annual prevalence and incidence were predicted using time series analysis.</p><p><strong>Results: </strong>The crude cumulative prevalence of exudative AMD was 42.7 in 2022, with men having a higher prevalence than women (51.3 vs. 34.6). The annual prevalence rose from 10.7 in 2013 to 22.5 in 2022 (age-standardized, <i>P</i> < 0.001). The incidence consistently increased from 2.8 in 2013 to 4.7 in 2022 (age-standardized, <i>P</i> = 0.001), with higher incidence in men than in women. The prevalence and incidence of exudative AMD were higher in older age groups and showed a faster increase with advancing age. The predicted annual prevalence and incidence of exudative AMD in 2040 are 46.2 and 8.4, respectively. The crude cumulative number of patients was 127,044 in 2022 and is projected to reach 230,899 in 2030 and 374,282 in 2040.</p><p><strong>Conclusion: </strong>The prevalence and incidence of exudative AMD in Korea has been increased annually, especially in the elderly group. With the Korean and global population aging, there will be a growing burden from visual impairment and medical expenses associated with exudative AMD.</p>\",\"PeriodicalId\":16249,\"journal\":{\"name\":\"Journal of Korean Medical Science\",\"volume\":\"40 26\",\"pages\":\"e128\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12235191/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Korean Medical Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3346/jkms.2025.40.e128\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3346/jkms.2025.40.e128","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:更新渗出性年龄相关性黄斑变性(AMD)的最新流行病学对了解该疾病的流行病学趋势、制定医疗保健策略以及为全球比较提供数据至关重要。本研究旨在估计渗出性AMD在韩国的患病率和发病率的全国趋势。方法:在这项基于全国人群的研究中,使用国民健康保险服务数据,提取2013年至2022年年龄在40岁及以上的具有渗出性AMD登记代码的患者。估计2013年以来的累积患病率、年患病率和发病率为每1万人。我们还使用世界卫生组织的人口比例计算了年龄标准化估计值。对试验时间趋势进行线性回归。采用时间序列分析预测年患病率和发病率。结果:2022年渗出性AMD的粗累积患病率为42.7,男性患病率高于女性(51.3比34.6)。年患病率从2013年的10.7上升到2022年的22.5(年龄标准化,P < 0.001)。发病率持续上升,从2013年的2.8上升到2022年的4.7(年龄标准化,P = 0.001),男性的发病率高于女性。渗出性AMD的患病率和发病率在年龄较大的人群中较高,且随着年龄的增长增长较快。预计2040年渗出性AMD的年患病率和发病率分别为46.2和8.4。2022年累计患者数为12.7044万名,预计2030年和2040年将分别达到23.0899万名和37.4282万名。结论:渗出性AMD在韩国的患病率和发病率呈逐年上升趋势,尤其是在老年人中。随着韩国和世界人口老龄化,与渗出性AMD相关的视力损害和医疗费用负担将越来越大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

10-Year Change and Projection in Prevalence and Incidence of Exudative Age-Related Macular Degeneration in Korea.

10-Year Change and Projection in Prevalence and Incidence of Exudative Age-Related Macular Degeneration in Korea.

10-Year Change and Projection in Prevalence and Incidence of Exudative Age-Related Macular Degeneration in Korea.

10-Year Change and Projection in Prevalence and Incidence of Exudative Age-Related Macular Degeneration in Korea.

Background: Updating the recent epidemiology of exudative age-related macular degeneration (AMD) is crucial for understanding the epidemiological trend of the disease, preparing healthcare strategies, and providing data for global comparisons. This study aimed to estimate the nationwide trend in prevalence and incidence of exudative AMD in Korea.

Methods: In this nationwide population-based study using the National Health Insurance Service data, patients who have registration code for exudative AMD and aged 40 years or older were extracted from 2013 to 2022. Cumulative prevalence from 2013 onwards, annual prevalence, and incidence was estimated per 10,000 people. We also calculated age-standardized estimates using the World Health Organization population proportions. Linear regression to test time trend was performed. The annual prevalence and incidence were predicted using time series analysis.

Results: The crude cumulative prevalence of exudative AMD was 42.7 in 2022, with men having a higher prevalence than women (51.3 vs. 34.6). The annual prevalence rose from 10.7 in 2013 to 22.5 in 2022 (age-standardized, P < 0.001). The incidence consistently increased from 2.8 in 2013 to 4.7 in 2022 (age-standardized, P = 0.001), with higher incidence in men than in women. The prevalence and incidence of exudative AMD were higher in older age groups and showed a faster increase with advancing age. The predicted annual prevalence and incidence of exudative AMD in 2040 are 46.2 and 8.4, respectively. The crude cumulative number of patients was 127,044 in 2022 and is projected to reach 230,899 in 2030 and 374,282 in 2040.

Conclusion: The prevalence and incidence of exudative AMD in Korea has been increased annually, especially in the elderly group. With the Korean and global population aging, there will be a growing burden from visual impairment and medical expenses associated with exudative AMD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Korean Medical Science
Journal of Korean Medical Science 医学-医学:内科
CiteScore
7.80
自引率
8.90%
发文量
320
审稿时长
3-6 weeks
期刊介绍: The Journal of Korean Medical Science (JKMS) is an international, peer-reviewed Open Access journal of medicine published weekly in English. The Journal’s publisher is the Korean Academy of Medical Sciences (KAMS), Korean Medical Association (KMA). JKMS aims to publish evidence-based, scientific research articles from various disciplines of the medical sciences. The Journal welcomes articles of general interest to medical researchers especially when they contain original information. Articles on the clinical evaluation of drugs and other therapies, epidemiologic studies of the general population, studies on pathogenic organisms and toxic materials, and the toxicities and adverse effects of therapeutics are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信